BAM Logo

Drugs of Abuse in Hair Scheme (DAH)

EPTIS factsheet 136731 | Last revision 2019-12-04 | URL: https://www.eptis.bam.de/pts136731 https://www.eptis.bam.de/pts136731

PT provider
PT provider LGC AXIO Proficiency Testing LGC AXIO Proficiency Testing
Based in United Kingdom
Remarks Human segmented hair impregnated with drugs of abuse and metabolites Amfetamine group, Benzodiazepine group, Cannabinoids (THC), Cocaine group, Opiate group
Product groups Hazardous substances
Human test material
Pharmaceutical products, drugs
Testing fields Medical analysis
Technical details
Test item Tested property Testing method
Human hair Amfetamines For the identification and quantification of up to 4 analytes
Benzodiazepines -
Opiate group -
Tetrahydrocannabinol (THC) -
Cocaine metabolites group -
Cannabinoids -
Opiates -
Methadone EDDP -
Buprenorphine -
Norbuprenorphine -
Ketamine -
Norketamine -
Other current drugs and/or metabolites may also be included -
Aims of the PT scheme
Target group of participants
Linked to specific legislation / standards
Additional, subsidiary aims
Number of participants
Accredited or otherwise reviewed by a 3rd party
Operation is commissioned / requested by
Fees and frequency
Participation fee Depending on samples taken
Regularly operated Yes (4 rounds per annum)
Year of first operation 2013
Contact details of the PT provider
Provider Contact person
LGC AXIO Proficiency Testing
1 Chamberhall Business Park, Chamberhall Green
BL9 0AP Bury, Greater Manchester
United Kingdom

Phone: +44 (0)161 762 2500
Fax: +44 (0)161 762 2501
Web: https://www.lgcstandards.com/GB/en/Proficiency-Testing/cat/244597 https://www.lgcstandards.com/GB/en/Proficiency-Testing/cat/244597
Mrs Nicola Armstrong
Phone: +44 (0)161 762 2500
Email: nicola.armstrong@lgcgroup.com nicola.armstrong@lgcgroup.com
If you find any mistakes please contact the responsible EPTIS coordinator in United Kingdom, Mr Savvas Xystouris. Mr Savvas Xystouris.
Any questions or problems? Please contact us at eptis@bam.de.
Application version: 1.21